NCT04862949 2025-12-12Organ-specific Responses to Atezolizumab Plus Bevacizumab in Advanced HCCCHA UniversityCompleted131 enrolled 8 charts
NCT06199297 2024-01-26Atezolizumab Plus Bevacizumab Versus Sintilimab Plus Bevacizumab With TACE and HAIC in Unresectable Hepatocellular CarcinomaSun Yat-sen UniversityCompleted188 enrolled